Cited In for PMID: 31189728

Year	Number of Results
2019	1
2020	18
2021	8
2022	7
2023	7
2024	0

1

Clinically Advanced p38 Inhibitors Suppress DUX4 Expression in Cellular and Animal Models of Facioscapulohumeral Muscular Dystrophy.

Oliva J, Galasinski S, Richey A, Campbell AE, Meyers MJ, Modi N, Zhong JW, Tawil R, Tapscott SJ, Sverdrup FM. Oliva J, et al. J Pharmacol Exp Ther. 2019 Aug;370(2):219-230. doi: 10.1124/jpet.119.259663. Epub 2019 Jun 12. J Pharmacol Exp Ther. 2019. PMID: 31189728 Free PMC article.

2

Flavones provide resistance to DUX4-induced toxicity via an mTor-independent mechanism.

Cohen J, Huang S, Koczwara KE, Woods KT, Ho V, Woodman KG, Arbiser JL, Daman K, Lek M, Emerson CP Jr, DeSimone AM. Cohen J, et al. Cell Death Dis. 2023 Nov 16;14(11):749. doi: 10.1038/s41419-023-06257-2. Cell Death Dis. 2023. PMID: 37973788 Free PMC article.

3

Apabetalone, a Clinical-Stage, Selective BET Inhibitor, Opposes DUX4 Target Gene Expression in Primary Human FSHD Muscle Cells.

Sarsons CD, Gilham D, Tsujikawa LM, Wasiak S, Fu L, Rakai BD, Stotz SC, Carestia A, Sweeney M, Kulikowski E. Sarsons CD, et al. Biomedicines. 2023 Sep 30;11(10):2683. doi: 10.3390/biomedicines11102683. Biomedicines. 2023. PMID: 37893058 Free PMC article.

4

Pharmacotherapeutic Approaches to Treatment of Muscular Dystrophies.

Rawls A, Diviak BK, Smith CI, Severson GW, Acosta SA, Wilson-Rawls J. Rawls A, et al. Biomolecules. 2023 Oct 17;13(10):1536. doi: 10.3390/biom13101536. Biomolecules. 2023. PMID: 37892218 Free PMC article. Review.

5

DUX4 expression in cancer induces a metastable early embryonic totipotent program.

Smith AA, Nip Y, Bennett SR, Hamm DC, Lemmers RJLF, van der Vliet PJ, Setty M, van der Maarel SM, Tapscott SJ. Smith AA, et al. Cell Rep. 2023 Sep 26;42(9):113114. doi: 10.1016/j.celrep.2023.113114. Epub 2023 Sep 8. Cell Rep. 2023. PMID: 37691147 Free PMC article.

6

Influence of DUX4 Expression in Facioscapulohumeral Muscular Dystrophy and Possible Treatments.

Duranti E, Villa C. Duranti E, et al. Int J Mol Sci. 2023 May 30;24(11):9503. doi: 10.3390/ijms24119503. Int J Mol Sci. 2023. PMID: 37298453 Free PMC article. Review.

7

Flavones provide resistance to DUX4-induced toxicity via an mTor-independent mechanism.

Cohen J, Huang S, Koczwara K, Ho V, Woodman K, Lek A, Arbiser J, Lek M, DeSimone A. Cohen J, et al. Res Sq [Preprint]. 2023 Feb 2:rs.3.rs-2452222. doi: 10.21203/rs.3.rs-2452222/v1. Res Sq. 2023. PMID: 36778471 Free PMC article. Updated. Preprint.

8

Human DUX4 and porcine DUXC activate similar early embryonic programs in pig muscle cells: implications for preclinical models of FSHD.

Nip Y, Bennett SR, Smith AA, Jones TI, Jones PL, Tapscott SJ. Nip Y, et al. Hum Mol Genet. 2023 May 18;32(11):1864-1874. doi: 10.1093/hmg/ddad021. Hum Mol Genet. 2023. PMID: 36728804 Free PMC article.

9

A feasibility study of noninvasive prenatal diagnosis in facioscapulohumeral muscular dystrophy type 1 in a Chinese family.

Qin Y, Xu H, Yang J, Wu Y, Li H, Wang B, Liu L, Ren D, Xu R, Li M, Zhang C, Song J. Qin Y, et al. Front Genet. 2022 Oct 25;13:1046096. doi: 10.3389/fgene.2022.1046096. eCollection 2022. Front Genet. 2022. PMID: 36386852 Free PMC article.

10

DUX4 expression activates JNK and p38 MAP kinases in myoblasts.

Brennan CM, Hill AS, St Andre M, Li X, Madeti V, Breitkopf S, Garren S, Xue L, Gilbert T, Hadjipanayis A, Monetti M, Emerson CP, Moccia R, Owens J, Christoforou N. Brennan CM, et al. Dis Model Mech. 2022 Nov 1;15(11):dmm049516. doi: 10.1242/dmm.049516. Epub 2022 Oct 31. Dis Model Mech. 2022. PMID: 36196640 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

38 results

Results by year